The dream is almost over...don't worry, look ahead

Lung Cancer

Volumn 40, Issue 2, 2003, Pages 187-190

  Scagliotti, Giorgio V ^a   Novello, Silvia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CISPLATIN; CYTOTOXIC AGENT; MOLECULAR MARKER; UFT;

ADJUVANT CHEMOTHERAPY; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; DIAGNOSTIC IMAGING; DISEASE SEVERITY; EARLY DIAGNOSIS; HISTOLOGY; HUMAN; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; METASTASIS; MORTALITY; NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; SURVIVAL RATE; SYSTEMIC THERAPY;

EID: 0037404050     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00080-1     Document Type: Note

References (26)

1. Parkin D.M., Pisani P., Ferlay J. Global cancer statistics. CA Cancer J. Clin. 49:1999;33-64.
2. Khuri J.M., Spitz M.R., Hong W.K. Lung chemoprevention: targeting former rather than current smokers. Cancer Prev. Int. 2:1995;55.
3. Morita K., Fuwa N., Suzuki Y., et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother. Oncol. 42:1997;31-36.
4. Bush D.A., Slater J.D., Bonnet R., et al. Proton-beam radiotherapy for early stage lung cancer. Chest. 116:1999;1313-1319.
5. Nesbitt J.C., Putnam J.B. Jr., Walsh G.L., et al. Survival in early-stage non-small cell lung cancer. Ann. Thorac. Surg. 60:1995;466-472.
6. Pairolero P., Williams D., Bergstralh M., et al. Post-surgical stage I bronchogenic carcinoma. Morbid implications of recurrent disease. Ann. Thorac. Surg. 38:1984;331-338.
7. Thomas P., Rubenstein I. Cancer recurrence after resection T1N0 non-small cell lung cancer. Ann. Thorac. Surg. 48:1990;242-247.
8. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N. Engl. J. Med. 343:2000;254-261.
9. Gupta N.C., Graeber G.M., Rogers J.S. II, et al. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. Ann. Surg. 229:1999;286-291.
10. Weder W., Schmid R.A., Bruchhaus H., et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann. Thorac. Surg. 66:1998;886-892.
11. Petty T.L. Screening strategies for early detection of lung cancer. The time is now. JAMA. 284:2000;1977-1980.
12. Passlick B., Izbicki J.R., Kubuschok B., et al. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann. Thorac. Surg. 1996;61-177.
13. Cote R.J., Hawes D., Chaiwun B., et al. Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging. J. Surg. Oncol. 69:1998;265-274.
14. Ohgami A., Mitsudomi T., Sugio K., et al. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann. Thorac. Surg. 64:1997;363-367.
15. Passlick B., Kubuschok B., Izbicki J.R., et al. Isolated tumor cells in the bone marrow predict reduced survival in node-negative non-small cell lung cancer. Ann. Thorac. Surg. 68:1999;2053-2058.
16. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials. Lancet. 352:1998;257-263.
17. Machtay M., Lee J.H., Shrager J.B., Kaiser L.R., Glatstein E. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small cell lung carcinoma. J. Clin. Oncol. 19:2001;3912-3917.
18. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br. Med. J. 311:1995;899-909.
19. Systemic treatment of early breast cancer by hormonal, cytotoxic and immune therapy. Lancet. 339:(1-15):1992;71-85.
20. Keller S.M., Adak S., Wagner H., et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small cell lung cancer. N. Engl. J. Med. 343:2000;1217-1222.
21. M. Tonato, on behalf of the ALPI/EORTC-LCCG investigators. Final report of the Adjuvant Lung Project Italy (ALPI): an Italian/EORTC-LCCG randomised trial of adjuvant chemotherapy in completely resected non-small cell lung cancer. Proc. Am. Soc. Clin. Oncol. 2002; 21: 290a (abstract 1157).
22. The Study Group of Adjuvant Chemotherapy for Lung Cancer: a randomised trial of postoperative adjuvant chemotherapy in non-small cell lung cancer. Eur. J. Surg. Oncol. 1995; 21: 69-77.
23. Wada H., Hitami S., Teramatsu T., et al. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J. Clin. Oncol. 14:1996;1048-1054.
24. Wada H., Miyahara R., Tanaka F., et al. Postoperative adjuvant chemotherapy with PVM and UFT in resected stage I-II NSCLC: a randomised clinical trial. Eur. J. Cardiothor. Surg. 15:1999;438-443.
25. C. Endo, Y. Saito, H. Iwanami, et al. A randomised trial of post-operative UFT therapy in stage I,II non-small cell lung cancer: north-east Japan study group for lung cancer surgery. Lung Cancer, in press.
26. Pisters K.M., Ginsberg R.J., Giroux D.J., et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. Bimodality Lung Oncology Team. J. Thorac. Cardiovasc. Surg. 119:2000;429-439.